Antifibrotic effect of pyrimidine derivatives of Xymedon and its conjugate with L-ascorbic acid

This article considers the antifibrotic properties of pyrimidine derivatives of the drug Xymedon (compound (I)) and its conjugate with L-ascorbic acid (compound (II)) in an experimental rat model of fibrosis with a preventive administration scheme.Experimental fibrosis was induced in Wistar rats giv...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Учёные записки Казанского университета: Серия Естественные науки
المؤلفون الرئيسيون:	G. P. Belyaev, A. B. Vyshtakalyuk, A. A. Parfenov, I. V. Galyametdinova, V. E. Semenov, V. V. Zobov
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Kazan Federal University 2023-12-01
الموضوعات:	fibrosis antifibrotic effect collagen xymedon carbon tetrachloride
الوصول للمادة أونلاين:	https://uzakuesc.elpub.ru/jour/article/view/13

مواد مشابهة

Xymedon and its conjugate with <i>L</i>-ascorbic acid for treating experimentally induced liver fibrosis in rats
حسب: G. P. Belyaev, وآخرون
منشور في: (2025-06-01)

Anti-apoptosis mechanism of the hepatoprotective effect of pyrimidine derivatives in in vivo studies
حسب: A.A. Parfenov, وآخرون
منشور في: (2022-06-01)

The Effect of Zinc Oxide Nanoparticles on Properties and Burn Wound Healing Activity of Thixotropic Xymedone Gels
حسب: Ilya Sheferov, وآخرون
منشور في: (2022-10-01)

Antifibrotic therapy of idiopathic pulmonary fibrosis: efficiency / safety ratio
حسب: S. N. Avdeev, وآخرون
منشور في: (2018-10-01)

Physalis angulata Linn. As a Potential Liver Antifibrotic Agent In Rats.
حسب: Muhammad Begawan Bestari, وآخرون
منشور في: (2024-01-01)

Lung fibrosis in sarcoidosis. Is there a place for antifibrotics?
حسب: Karol Bączek, وآخرون
منشور في: (2024-08-01)

Emergent Peptides of the Antifibrotic Arsenal: Taking Aim at Myofibroblast Promoting Pathways
حسب: Zhen Liu, وآخرون
منشور في: (2023-07-01)

Apigenin as a multifaceted antifibrotic agent: Therapeutic potential across organ systems
حسب: Xiaoyong Hu, وآخرون
منشور في: (2025-06-01)

Exploring the Antifibrotic Mechanisms of Ghrelin: Modulating TGF-β Signalling in Organ Fibrosis
حسب: Mei Li, وآخرون
منشور في: (2025-01-01)

Antifibrotics and mortality in idiopathic pulmonary fibrosis: external validity and avoidance of immortal time bias
حسب: Hironao Hozumi, وآخرون
منشور في: (2024-07-01)

The effect of antifibrotics on the progression of pulmonary hypertension in patients with interstitial lung disease listed for lung transplantation
حسب: Christopher Thomas, وآخرون
منشور في: (2025-09-01)

Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosis
حسب: Nesrin Ocal, وآخرون

Serum markers of the extracellular matrix remodelling reflect antifibrotic therapy in bile-duct ligated rats.
حسب: Robert eSchierwagen, وآخرون
منشور في: (2013-07-01)

Screening for Antifibrotic Compounds Using High Throughput System Based on Fluorescence Polarization
حسب: Branko Stefanovic, وآخرون
منشور في: (2014-04-01)

Pathogenetic bases of the use of antifibrotic therapy with Bovhyaluronidazum azoximerum in patients with new coronavirus infection COVID-19
حسب: O. A. Chernyavskaya, وآخرون
منشور في: (2021-09-01)

The current landscape of antifibrotic therapy across different organs: A systematic approach
حسب: Isabel Fuster-Martínez, وآخرون
منشور في: (2024-07-01)

The Antifibrotic and the Anticarcinogenic Activity of Capsaicin in Hot Chili Pepper in Relation to Oral Submucous Fibrosis
حسب: Zoufang Huang, وآخرون
منشور في: (2022-05-01)

Pharmacological support in the perioperative period of implantation of a polypropylene mesh prosthesis (experimental study)
حسب: E. E. Lukoyanychev, وآخرون
منشور في: (2022-03-01)

The Role of Antifibrotic Therapy in Pulmonary Fibrosis and Lung Cancer: A Multicenter Retrospective Analysis
حسب: Francesco Rocco Bertuccio, وآخرون
منشور في: (2025-09-01)

Effectiveness and Safety of Antifibrotic Treatment in Pulmonary Fibrosis Associated with Rheumatoid Arthritis
حسب: Martyna Magdalena Martka, وآخرون
منشور في: (2024-07-01)

The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis
حسب: Stefano Kette, وآخرون
منشور في: (2025-03-01)

The novel role of β-aescin in attenuating CCl4-induced hepatotoxicity in rats
حسب: Harsimran Singh, وآخرون
منشور في: (2017-01-01)

Blood Krebs von den Lungen-6 levels predict treatment response to antifibrotic therapy in patients with idiopathic pulmonary fibrosis
حسب: Myeong Geun Choi, وآخرون
منشور في: (2022-12-01)

The impact of antifibrotic use on long-term clinical outcomes in the pulmonary fibrosis foundation registry
حسب: Cathryn T. Lee, وآخرون
منشور في: (2024-06-01)

Synthesis and Biological Evaluation of Novel Thiazolyl-Coumarin Derivatives as Potent Histone Deacetylase Inhibitors with Antifibrotic Activity
حسب: Viviana Pardo-Jiménez, وآخرون
منشور في: (2019-02-01)

General views on treatment technologies for patients with incisional ventral hernia
حسب: E. E. Lukoyanychev, وآخرون
منشور في: (2021-09-01)

Real-world treatment persistence and predictive factors for discontinuation of antifibrotic therapies in patients with idiopathic pulmonary fibrosis: a post-hoc analysis of two multicenter observational cohort studies in Poland
حسب: Sebastian Majewski, وآخرون
منشور في: (2025-06-01)

The use of bicyclol in the treatment of severe liver fibrosis: experimental rationale
حسب: K. V. Zhdanov, وآخرون
منشور في: (2021-01-01)

Design, Synthesis and Antifibrotic Activities of Carbohydrate- Modified 1-(Substituted aryl)-5-trifluoromethyl-2(1H) Pyridones
حسب: Lijian Tao, وآخرون
منشور في: (2012-01-01)

Antifibrotic Drug Delivery for Glaucoma Treatment – Determination of Josamycin in vivo
حسب: Eickner Thomas, وآخرون
منشور في: (2024-12-01)

Radiomics for the Prediction of Response to Antifibrotic Treatment in Patients with Idiopathic Pulmonary Fibrosis: A Pilot Study
حسب: Cheng-Chun Yang, وآخرون
منشور في: (2022-04-01)

Gender Differences Are a Leading Factor in 5-Year Survival of Patients with Idiopathic Pulmonary Fibrosis over Antifibrotic Therapy Reduction
حسب: Pasquale Tondo, وآخرون
منشور في: (2025-01-01)

Reversal of liver fibrosis
حسب: Ismail Mona, وآخرون
منشور في: (2009-01-01)

Soluble human macrophage factors are able to inhibit TGF-β-induced differentiation of lung fibroblasts
حسب: A. A. Maksimova, وآخرون
منشور في: (2024-07-01)

Liver fibrosis is driven by protease‐activated receptor‐1 expressed by hepatic stellate cells in experimental chronic liver injury
حسب: Lauren G. Poole, وآخرون
منشور في: (2020-07-01)

Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery
حسب: Michelle T. Sun, MBBS, PhD, وآخرون
منشور في: (2024-05-01)

Antifibrotic effects of crocetin in scleroderma fibroblasts and in bleomycin-induced sclerotic mice
حسب: Yinghua Song, وآخرون
منشور في: (2013-10-01)

Idiopathic pulmonary fibrosis: a clinical case of long-term follow-up
حسب: Galina L. Ignatova, وآخرون
منشور في: (2022-09-01)

Liposomal Forms of Fluoroquinolones and Antifibrotics Decorated with Mannosylated Chitosan for Inhalation Drug Delivery
حسب: Irina Le-Deygen, وآخرون
منشور في: (2023-03-01)

The Ameliorative Effects of Allopurinol on Paraquat-Induced Pulmonary Fibrosis in Rats
حسب: Saeedeh Shariati, وآخرون
منشور في: (2019-03-01)